These rankings are based on data from March 2026
Company
GEn1E Lifesciences Inc.
Years in business
- 8
Number of employees
- 11-50 employees
Country
- United States
GEn1E Lifesciences employs a machine learning-driven approach to accelerate the development of first-in-class therapies for inflammatory diseases, utilizing unique allosteric binding mechanisms to improve specificity and reduce side effects.
API Availability
- No
Pricing
paid
Position of GEn1E Lifesciences on sub rankings
March 2026
AI drug discovery & development - Overall
20 out of 62
United States - Overall
3,674 out of 17,204
AI drug discovery & development - Overall
20 out of 62
United States - Overall
3,674 out of 17,204
Industries
health & sports
Security protocols
ccpa
Company
GEn1E Lifesciences Inc.
Years in business
- 8
Number of employees
- 11-50 employees
Country
- United States
Insights
9 Fresh AI Tools: From scam checks to startup plans
This month brought another strong batch of new submissions to RankmyAI. Thanks again to the builders and users who keep pointing us to tools we should track.
Sune Selsbæk-Reitz on promptism, fluent machines, and why AI makes it easier to stop thinking too soon
An interview with Sune Selsbæk-Reitz on his new book Promptism and why the real risk of AI is not in the technology itself, but in how we use it. He explains how fluent systems influence thinking, why knowledge matters more than ever, and what professionals should do to stay in control.